Keck School Faculty

Ashwat Singh Dhillon, MD
Ashwat Singh Dhillon, MD
Clinical Instructor of Medicine (Fellow)
HCT 1520 San Pablo St Health Sciences Campus Los Angeles
Dr. Dhillon’s research interests include management of coronary artery disease, valvular heart disease, peripheral vascular disease, hypertrophic cardiomyopathy and takotsubo cardiomyopathy.

Dr. Dhillon earned his medical degree from Bharati Vidyapeeth University Medical College in India. He then completed residency training at Fairview Hospital in Cleveland, Ohio, a research fellowship in cardiac imaging at Cleveland Clinic, and a vascular medicine fellowship the Keck Medical Center of the University of Southern California, where he is currently a fellow in Cardiology and a Clinical Instructor in Medicine.

Cleveland Clinic Hospital : Best PGY2 Resident in Internal Medicine, 2011-2012

Cleveland Clinic - Fairview Hospital : Best PGY2 Resident in Internal Medicine, 2011-2012

Therapeutic Window of Clopidogrel and Ticagrelor in Patients With Critical Limb-Threatening Ischemia J Cardiovasc Pharmacol Ther. 2020 Mar; 25(2):158-163. . View in PubMed

In-Hospital Outcomes of Rotational Atherectomy in High-Risk Patients With Severely Calcified Left Main Coronary Artery Disease: A Single-Center Experience J Invasive Cardiol. 2019 04; 31(4):101-106. . View in PubMed

Switch to Ticagrelor in critical limb ischemia antiplatelet study (STT-CLIPS) Cardiovasc Revasc Med. 2018 Apr - May; 19(3 Pt B):319-323. . View in PubMed

Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventionsEvidence from a meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2018 12; 19(8):951-955. . View in PubMed

Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteriaJ Thorac Cardiovasc Surg. 2018 08; 156(2):750-759. e3. . View in PubMed

Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia Cardiovasc Revasc Med. 2018 07; 19(5 Pt A):516-520. . View in PubMed

Comparison of devices used in carotid artery stenting: A vascular quality initiative analysis of commonly used carotid stents and embolic protection devices Catheter Cardiovasc Interv. 2018 10 01; 92(4):743-749. . View in PubMed

Hypertrophic cardiomyopathy and the potential influence of etomidate on postoperative outcomes Heart. 2016 Nov 15; 102(22):1852-1853. . View in PubMed

Disease-modifying medical therapy in phenotypically overt hypertrophic cardiomyopathy: a case of too little, too late? Heart. 2016 02 15; 102(4):260-1.. View in PubMed

Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery Heart. 2016 10 15; 102(20):1627-32. . View in PubMed

Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography Circ Cardiovasc Imaging. 2015 Jul; 8(7):e003132. . View in PubMed

Association of noninvasively measured left ventricular mechanics with in vitro muscle contractile performance: a prospective study in hypertrophic cardiomyopathy patients J Am Heart Assoc. 2014 Nov 11; 3(6):e001269. . View in PubMed

Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotomy/myectomy Am J Cardiol. 2014 Jun 01; 113(11):1879-85. . View in PubMed

Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarctionJ Card Fail. 2014 May; 20(5):377. e25-31. . View in PubMed

Incremental use of biomarkers and electrocardiogram in differentiating takotsubo cardiomyopathy from acute myocardial infarction: a potential way to go J Card Fail. 2014 Apr; 20(4):292-3. . View in PubMed

Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction J Card Fail. 2014 Jan; 20(1):2-8. . View in PubMed

Cardiac magnetic resonance in hypertrophic cardiomyopathy JACC Cardiovasc Imaging. 2011 Oct; 4(10):1123-37. . View in PubMed

Cardiac magnetic resonance in hypertrophic cardiomyopathy Curr Cardiol Rep. 2011 Feb; 13(1):67-76. . View in PubMed

Powered by SC CTSI
Go to Top